Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrating PrEP Into Mobile Addiction and Primary Care Services
NCT06908252Phase 4Completed
- Sponsor
- Duke University
- Start
- Sep 2025
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in human immunodeficiency virus infection (HIV), sponsored by Duke University. Primary endpoints: Enrollment, Negative HIV Status at 6 months and 4 more. Started Sep 2025; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06908252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06908252.